Bioclassic is a flagship biostimulant from NPP, UPL’s Natural Plant Protection biologicals business
| Photo Credit:
UPL, through its subsidiary SWAL, has secured a Fertilizer Control Order (FCO) registration for Bioclassic, a flagship biostimulant from NPP, UPL’s Natural Plant Protection biologicals business. This milestone enables Bioclassic to become available to farmers across India, the company said in a statement.Developed using a proprietary fermentation process, Bioclassic is formulated as a soluble concentrate. The biostimulant is recommended for application twice during the vegetative stage at ultra-low dose rates to enhance key traits such as branching and photosynthesis. This drives resource accumulation, improves plant vigour, mitigates stress and contributes to incremental yield gains.Bioclassic has demonstrated high efficacy under varied climatic and soil conditions during field trials. This biostimulant is recommended for application with conventional sprayers and, where permitted, can also be applied using drone-based platforms in accordance with applicable standard operating procedures.Ravishankar Cherukuri, CEO, UPL SAS, said: “Bioclassic is designed to address the real-world stress conditions that Indian farmers frequently face - from extreme heat to the widespread challenge of high-alkaline soils across several states. Backed by scientific validation across geographies, Bioclassic’s registration highlights the growing potential of biologicals to strengthen farm resilience. It also reaffirms our commitment to offer scientifically validated, compliant solutions that enhance long-term sustainability.”Anil Rohra, Global NPP Business Unit Leader, added, “Bioclassic is an integral part of UPL’s ProNutiva approach, that combines conventional crop protection solutions with advanced biosolutions to promote sustainable farming practices. By improving resource efficiency and supporting long-term crop health, Bioclassic can deliver significant value for oilseeds, pulses and vegetables.”In addition to Bioclassic, UPL has secured registration approvals for four more biostimulants - Opteine, Gaxy, Macarena and Pilatus -- in India, marking a significant expansion of its biosolutions portfolio, the company said.Published on May 26, 2026
